Ipratropium bromide/salbutamol Azure 0.5 mg/2.5 mg per 2.5 ml Nebuliser Solution

{
  "form": "Nebuliser solution",
  "routes": [
    "Inhalation use"
  ],
  "source": "hpra",
  "atc_all": [
    "R03AL02"
  ],
  "strength": null,
  "pa_number": "PA22871/033/001",
  "substances": [
    "Ipratropium bromide monohydrate",
    "Salbutamol sulfate"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "06/03/2026",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}